Press Release: Quethera : Neuroprotective Therapy Company Quethera Reveals Gene Therapy Results at ARVO

Quethera presents efficacy data showing an 83% increase in retinal ganglion cell survival in chronic in vivo glaucoma models. Baltimore, MD & Cambridge, UK (PRWEB UK) 18 May 2017 Quethera, a biopharmaceutical company developing therapies for ocular disorders, today presented strong efficacy data at the 2017 Association for Research in Vision and Ophthalmology (ARVO) conference [...]The post Neuroprotective Therapy Company Quethera Reveals Gene Therapy Results at ARVO appeared first on Press Release Rocket.